Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05710627 · ClinicalTrials.gov registry record · NA
Evaluation of TENEX for Greater Trochanteric Pain Syndrome (GTPS)
A NA study of Greater Trochanteric Pain Syndrome, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05710627 is a NA study of Greater Trochanteric Pain Syndrome that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05710627, a NA study of Greater Trochanteric Pain Syndrome, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate how an ultrasound-guided percutaneous procedure, TENEX, can help people with chronic hip pain resulting from a condition called Greater Trochanteric Pain Syndrome (GTPS) and to characterize the efficacy of percutaneous tenotomy (PUT) using TENEX®, a device used for the treatment of various tendinopathies. In this study an ultrasound (US) is performed to guide the partial release of gluteus medius and minimus and Iliotibial band tendons in patients diagnosed with refractory Greater Trochanteric Pain Syndrome (GTPS) vs control. The investigator team hypothesizes that the new TENEX can improve the pain level for individuals with GTPS to help those individuals perform their activities of daily living (ADLs), e.g., walking, standing, and side-lying, as well as demonstrate less medication utilization. The study predicts that this percutaneous outpatient procedure can decrease pain, increase mobility, and decrease medication utilization. The study team hypothesizes that PUT can improve the pain level and function for individuals suffering with GTPS. The study will assess walking, standing, and side-lying tolerance, as well as medication utilization. The investigator team predicts that this percutaneous outpatient procedure can decrease pain and medication utilization while increasing mobility.
Conditions Studied
Interventions
- DEVICE TENEX
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-03-11 |
| Est. Completion | 2027-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05710627
The ClinicalTrials.gov registry entry for NCT05710627 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Greater Trochanteric Pain Syndrome appearing as the primary indexed condition, and to 1 intervention - of which TENEX is the first listed.
NCT05710627 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05710627 about?
NCT05710627 is a clinical study titled "Evaluation of TENEX for Greater Trochanteric Pain Syndrome (GTPS)". The objective of this study is to evaluate how an ultrasound-guided percutaneous procedure, TENEX, can help people with chronic hip pain resulting from a condition called Greater Trochanteric Pain Syndrome (GTPS) and to characterize the efficacy of percutaneous tenotomy (PUT) using TENEX®, a device ...
What is the current status of trial NCT05710627?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-03-11. Estimated completion is 2027-03.
What conditions does trial NCT05710627 study?
This clinical trial studies the following conditions: Greater Trochanteric Pain Syndrome.
What interventions are being tested in trial NCT05710627?
The interventions under investigation include: TENEX (DEVICE).
Who is sponsoring clinical trial NCT05710627?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05710627 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.